Higher Bupropion Doses Increase Fall Risk in Older Adults With Depression
A secondary analysis of the OPTIMUM trial found that higher doses of bupropion and prior fall history significantly increase fall risk in older adults with treatment-resistant depression receiving antidepressant augmentation.